Muthiah Y D, Lee W L, Teh L K, Ong C E, Salleh M Z, Ismail R
Pharmacogenetics Study Group, Institute for Research in Molecular Medicine and Department of Pharmacology, School of Medical Sciences, Universiti Sains Malaysia, 16150 Kota Bharu, Kelantan, Malaysia.
Clin Chim Acta. 2004 Nov;349(1-2):191-8. doi: 10.1016/j.cccn.2004.06.024.
Cytochrome P450 (CYP) 2C8 is a principle enzyme responsible for the metabolism of many clinically important drugs as well as endogenous compounds such as arachidonic acid. The enzyme is genetically polymorphic but a simple method is not available to study its genetic polymorphism. We developed and optimized a variant-specific PCR techniques to detect CYP2C82, CYP2C83 and CYP2C8*4.
Genomic DNA was extracted from blood using standard extraction methods. A two-step PCR method was developed to detect simultaneously three CYP2C8 variants. In the first PCR (PCR1), specific regions from exons 3, 5 and 8 of the CYP2C8 gene were amplified. The products were used as templates in parallel alleles-specific PCR (PCR2). This method was tested against DNA samples obtained from 57 healthy Malaysian volunteers.
The bands of interest were successfully amplified. This method showed specific and reproducible results when tested on healthy volunteers. DNA sequencing further confirmed genotype results obtained from current method.
We have successfully developed and optimized a multiplex PCR method suitable for use in population studies of CYP2C8 polymorphism.
细胞色素P450(CYP)2C8是一种主要酶,负责许多临床重要药物以及内源性化合物如花生四烯酸的代谢。该酶具有基因多态性,但尚无简单方法用于研究其基因多态性。我们开发并优化了一种变异特异性PCR技术,以检测CYP2C82、CYP2C83和CYP2C8*4。
采用标准提取方法从血液中提取基因组DNA。开发了一种两步PCR方法,以同时检测三种CYP2C8变异体。在第一次PCR(PCR1)中,扩增CYP2C8基因外显子3、5和8的特定区域。产物用作平行等位基因特异性PCR(PCR2)的模板。该方法针对从57名健康马来西亚志愿者获得的DNA样本进行了测试。
成功扩增出感兴趣的条带。该方法在健康志愿者中测试时显示出特异性和可重复性结果。DNA测序进一步证实了从当前方法获得的基因型结果。
我们已成功开发并优化了一种适用于CYP2C8多态性群体研究的多重PCR方法。